November 26, 2015
Recommended Topic Related To:


"Teriflunomide (Aubagio, Genzyme/Sanofi), a once-daily oral medication approved for relapsing-remitting multiple sclerosis (RRMS), significantly slows brain volume loss in these patients, a reanalysis of imaging data has shown.





Signs and Symptoms

Vomiting, muscular hypotonia, drowsiness, accommodation disorders, coma, respiratory depression, and seizures.


In the alert patient, empty the stomach promptly by induced emesis followed by lavage. In the obtunded patient, secure the airway with a cuffed endotracheal tube before beginning lavage (do not induce emesis). Maintain adequate respiratory exchange, do not use respiratory stimulants. It is unknown what effect hemodialysis or peritoneal dialysis has on the serum concentration of baclofen.


KEMSTRO™ (baclofen) is contraindicated in patients who are hypersensitive to any component of this product.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/20/2007


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Multiple Sclerosis

Get the latest treatment options.